Why Is Trevi Therapeutics, Inc. (NASDAQ: TRVI) Stock Down Today?

Trevi Therapeutics, Inc. (NASDAQ: TRVI) Summary

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is trading down -0.40% at $14.89, reflecting a negative shift in investor sentiment today. The stock opened at $14.96 and has moved between $14.59 and $15.11 so far.

Trading volume is 1649385, which is 23% below its average, and the price action suggests selling interest.

Technically, TRVI on the NASDAQ is trading below its 50-day moving average of $17.49 and above its 200-day moving average of $14.20, indicating short-term weakness but long-term strength.

Analyst sentiment is bullish. Meyka's AI assigns TRVI a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +18.67% in 1 month ($17.67), +34.15% in 1 year ($19.98), and +271.06% in 5 years ($55.25).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.